Cholangitis (original) (raw)
Latest News for: cholangitis
Open for public comment: AGA/AASLD joint guideline on the management of primary biliary cholangitis (AGA - American Gastroenterological Association Inc)
Public Technologies 12 Jun 2026
). The text version of this document is not available ... Attachments Original document Permalink.
Primary Sclerosing Cholangitis Market is Projected to Boom by 2034 Owing to the Launch of ...
GetNews 03 Jun 2026
The Primary Sclerosing Cholangitis market is set for growth, driven by rising diagnosed cases, greater disease awareness, and advancing therapies ... Key Takeaways from the Primary Sclerosing Cholangitis Market ... What is Primary Sclerosing Cholangitis?.
Zydus Therapeutics New Drug Application (NDA) for Saroglitazar to Treat Primary Biliary Cholangitis (PBC) Granted Priority Review by the US FDA
PR Newswire 28 May 2026
About Primary Biliary Cholangitis (PBC).PBC is a rare, progressive autoimmune disease that gradually destroys the bile ducts, resulting in an accumulation of bile in the liver, which can result in ...
Know the difference between certain types of cholangitis
Richmond Times Dispatch 27 May 2026
DEAR DR. ROACH. I read your recent column on primary sclerosing cholangitis. What is the difference between this condition and primary biliary cholangitis? Where can I find information on how to get on a waiting list for a liver transplant? ....
Dr. Roach: Know the difference between certain types of cholangitis
Traverse City Record-Eagle 27 May 2026
Dear Dr. Roach. I read your recent column on primary sclerosing cholangitis. What is the difference between this condition and primary biliary cholangitis? Where can I find information on how to get on a waiting list for a liver transplant? ... .
Mirum Pharmaceuticals to Host Investor Call to Share Topline Results from the VISTAS Study of Volixibat in Patients with Primary Sclerosing Cholangitis on May 4, 2026 (Mirum Pharmaceuticals Inc)
Public Technologies 03 May 2026
PT to share topline results from the VISTAS study of volixibat in patients with primary sclerosing cholangitis (PSC).
Primary Biliary Cholangitis Pipeline Set for Major Breakthroughs by 2026 with 25+ Therapies and Strong ...
GetNews 17 Apr 2026
"Primary Biliary Cholangitis Pipeline". Primary Biliary Cholangitis Companies such as Genfit, Zydus Discovery, Ohara Pharmaceutical, Chia Tai Tianqing Pharmaceutical Group Co ... Explore our latest breakthroughs in Primary Biliary Cholangitis Research.
Lynavoy (linerixibat) approved by the US FDA for cholestatic pruritus in patients with primary biliary cholangitis (PBC) (Form 6-K) (GSK plc)
Public Technologies 19 Mar 2026
). UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. Washington, D.C. 20549. Form 6-K ... UNDER THE SECURITIES EXCHANGE ACT OF 1934 ... . .X ... Lynavoy (linerixibat) approved by the US FDA for cholestatic pruritus in patients with primary biliary cholangitis (PBC).
Primary Sclerosing Cholangitis: Patient Voices in Rare Disease Care (Fortrea Holdings Inc)
Public Technologies 16 Mar 2026
Primary sclerosing cholangitis (PSC) is one such disease - rare, progressive, and still without an approved therapy ... This article will [...]. This is an abstract of the document ... Disclaimer ... (noodl. 130198539) .